0.8263

1.89% 0.0153

Xortx Therapeutics Inc (XRTX)

Overview News Price History Discussions Forecast Stock Split

Xortx Therapeutics Inc stock is traded at $0.8263, with a volume of 105.85K. It is up +1.89% in the last 24 hours and down -7.93% over the past month. XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

Previous Close:

$0.811

Open:

$0.8498

24h Volume:

105.85K

Relative Volume:

0.92

Market Cap:

$4.31M

Revenue:

Net Income/Loss:

$-736.70K

P/E Ratio:

-82.63

EPS:

-0.01

Net Cash Flow:

$-4.14M

1W Performance:

+0.16%

1M Performance:

-7.93%

6M Performance:

-10.19%

1Y Performance:

-51.39%

1-Day Range:

$0.8151

$0.86

1-Week Range:

$0.791

$0.86

52-Week Range:

$0.6608

$2.51

Xortx Therapeutics Inc Stock (XRTX) Company Profile

Name

Xortx Therapeutics Inc

Sector

Healthcare (1152)

Industry

Biotechnology (648)

Phone

Address

Employee

Twitter

Next Earnings Date

2024-11-12

Latest SEC Filings

XRTX's Discussions on Twitter

Compare XRTX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
XRTX Xortx Therapeutics Inc	0.8263	4.38M	0	-736.70K	-4.14M	-0.01
VRTX Vertex Pharmaceuticals Inc	394.53	99.62B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	465.89	61.52B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	560.00	58.91B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	756.38	46.69B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	324.34	34.54B	3.81B	-644.79M	-669.77M	-6.24

Xortx Therapeutics Inc (XRTX)

Xortx Therapeutics Inc Stock (XRTX) Company Profile

Compare XRTX with other stocks

Xortx Therapeutics Inc Stock (XRTX) Latest News

What technical models suggest about XORTX Therapeutics Inc.’s comebackQuarterly Portfolio Review & Precise Trade Entry Recommendations - Newser

Is it time to cut losses on XORTX Therapeutics Inc.July 2025 PostEarnings & Detailed Earnings Play Strategies - Newser

Pattern recognition hints at XORTX Therapeutics Inc. upside2025 Key Lessons & Free Verified High Yield Trade Plans - Newser

Strategies to average down on XORTX Therapeutics Inc.Market Trend Report & Intraday High Probability Setup Alerts - Newser

XORTX Therapeutics Inc. stock trendline breakdownJuly 2025 Patterns & Free Community Consensus Stock Picks - Newser

Real time breakdown of XORTX Therapeutics Inc. stock performanceJuly 2025 Patterns & Weekly High Momentum Picks - Newser

How to track smart money flows in XORTX Therapeutics Inc.Trade Ideas & Long-Term Investment Growth Plans - Newser

Building trade automation scripts for XORTX Therapeutics Inc.Quarterly Investment Review & Advanced Technical Signal Analysis - Newser

Is XORTX Therapeutics Inc. building a consolidation baseTrade Ideas & AI Optimized Trading Strategy Guides - Newser

Published on: 2025-09-12 12:52:08 - Newser

Multi factor analysis applied to XORTX Therapeutics Inc.Quarterly Trade Review & AI Driven Stock Movement Reports - Newser

Using Ichimoku Cloud for XORTX Therapeutics Inc. technicals2025 Pullback Review & High Accuracy Trade Signal Alerts - Newser

XORTX Therapeutics Inc. stock momentum explained2025 Market Overview & Long-Term Growth Portfolio Plans - Newser

Will XORTX Therapeutics Inc. continue its uptrendBuy Signal & Expert Curated Trade Ideas - Newser

How to integrate XORTX Therapeutics Inc. into portfolio analysis tools2025 Key Lessons & Weekly Top Gainers Alerts - Newser

Has XORTX Therapeutics Inc. formed a bullish divergence2025 Year in Review & Long-Term Capital Growth Ideas - Newser

Published on: 2025-09-12 01:56:47 - Newser

Tools to monitor XORTX Therapeutics Inc. recovery probabilityJuly 2025 Trends & Precise Trade Entry Recommendations - Newser

Reversal indicators forming on XORTX Therapeutics Inc. stockJuly 2025 Closing Moves & Long-Term Capital Growth Strategies - Newser

Should you wait for a breakout in XORTX Therapeutics Inc.July 2025 PostEarnings & Reliable Price Breakout Alerts - Newser

Drawdown in XORTX Therapeutics Inc. May Be Nearing EndJuly 2025 Opening Moves & Low Risk Investment Opportunities - Newser

trend analysis for xortx therapeutics inc. this weekJuly 2025 Selloffs & Verified Entry Point Detection - Newser

Applying Elliott Wave Theory to XORTX Therapeutics Inc.July 2025 Earnings & Smart Investment Allocation Insights - Newser

Understanding XORTX Therapeutics Inc.’s price movement2025 Year in Review & Fast Moving Stock Trade Plans - Newser

Institutional scanner results for XORTX Therapeutics Inc.Market Volume Report & AI Enhanced Trading Alerts - Newser

Published on: 2025-09-10 00:06:40 - Newser

What moving averages say about XORTX Therapeutics Inc.Market Growth Summary & Daily Chart Pattern Signals - Newser

Combining machine learning predictions for XORTX Therapeutics Inc.Insider Buying & AI Enhanced Trading Signals - Newser

Can XORTX Therapeutics Inc. disrupt its industryJuly 2025 Market Mood & Daily Technical Stock Forecast Reports - Lancaster City Council

Visual analytics tools that track XORTX Therapeutics Inc. performanceWeekly Stock Report & Free High Return Stock Watch Alerts - Newser

Should you hold or exit XORTX Therapeutics Inc. nowShare Buyback & AI Powered Market Entry Strategies - Newser

Is XORTX Therapeutics Inc. vulnerable to short sellersQuarterly Market Summary & Fast Gaining Stock Reports - Lancaster City Council

IPO Launch: Can XORTX Therapeutics Inc. disrupt its industryWall Street Watch & Risk Managed Investment Entry Signals - Lancaster City Council

XORTX Therapeutics goes ‘toe to toe’ with gout by accelerating its lead drug program targeting this complex disease - BNN Bloomberg

Chart overlay techniques for tracking XORTX Therapeutics Inc.Earnings Performance Report & Risk Controlled Swing Alerts - Newser

Published on: 2025-09-09 06:05:05 - Newser

Visual trend scoring systems applied to XORTX Therapeutics Inc.Recession Risk & Fast Exit/Entry Strategy Plans - Newser

Xortx Therapeutics Inc Stock (XRTX) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to XRTX